SCHEMBL21035666

SCHEMBL21035666

O=C(O)[C@@H]1C[C@@H](Oc2ccc(Cl)cc2)CCN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 3/20 0.49
ITGA4 P13612 3/20 0.49
HTR1A P08908 2/20 0.47
HTR7 P34969 2/20 0.47
HTR5A P47898 2/20 0.47
HTR1D P28221 1/20 0.47
HTR1B P28222 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
ADRA1A P35348 1/20 0.47
HTR2B P41595 1/20 0.47
HTR6 P50406 1/20 0.47
HTR4 Q13639 1/20 0.47
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
MMP1 P03956 1/20 0.41
ADAM17 P78536 1/20 0.41
HRH1 P35367 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035412 0.97 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035001 0.97 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034997 0.97 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035314 0.91 HTR1A (0.44) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035399 0.91 HTR1A (0.44) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034994 0.90 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034937 0.90 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21034999 0.90 ITGB1 (0.47) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035538 0.87 TSHR (0.46) ITGB1ITGA4HTR1AHTR7HTR5A
SCHEMBL21035132 0.87 TSHR (0.46) ITGB1ITGA4HTR1AHTR7HTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed